Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.77 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.77 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 8/20 | 0.48 |
| ▸ | CA2 | P00918 | 8/20 | 0.48 |
| ▸ | CA9 | Q16790 | 7/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL741918 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL604618 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL19812451 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL6725430 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL8745178 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL605336 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL193964 | 1.00 | — | — | |
| SCHEMBL8617447 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL3075008 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB | |
| SCHEMBL7518762 | 1.00 | ADRB2 (0.77) | ADRB2ADRB1ADRB3TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103958567-B | Alkoxylate polyalkylene polyamine | 巴斯夫欧洲公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105026538-A | Aqueous formulations, their preparation and their use in the cleaning of hard surfaces | BASF SE | 2015-11-04 | — | — | CN | disclosed |
| CN-104159977-A | Thermoplastic resin composition | NIPPON NYUKAZAI CO LTD | 2014-11-19 | — | — | CN | disclosed |
| CN-103958566-A | Increase of molar mass of polyalkylene polyamines by homogeneously catalyzed alcohol amination | BASF SE | 2014-07-30 | — | — | CN | disclosed |
| CN-103958567-A | Alkoxylated polyalkylene polyamines | BASF SE | 2014-07-30 | — | — | CN | disclosed |
| CN-103958568-A | Preparation of lipophilic polyalkylene polyamines by homogeneously catalyzed alcohol amination | BASF SE | 2014-07-30 | — | — | CN | disclosed |
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2013-05-09 | — | — | US | disclosed |
| US-8357636-B2 | Alkoxylated alkylamines/alkyl ether amines with peaked distribution | AKZO NOBEL N.V. (NL) | 2013-01-22 | — | — | US | disclosed |
| US-20120053054-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2012-03-01 | — | — | US | disclosed |
| US-8034979-B2 | Reacting primary alkylamine with alkylene oxide in absence of any functional proportion of alkali catalyst to yield first intermediate followed by reacting intermediate with additional moles of alkylene oxide at temperature of 90-130 degrees C. in absence of alkali catalyst to yield ethoxylated product | MONSANTO TECHNOLOGY LLC (US) | 2011-10-11 | — | — | US | disclosed |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | MONSANTO TECHNOLOGY LLC (US) | 2010-03-04 | — | — | US | disclosed |
| WO-2007109791-A9 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2009-01-15 | — | — | WO | disclosed |
| EP-2003965-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2008-12-24 | — | — | EP | disclosed |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | MONSANTO TECHNOLOGY LLC (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2007109791-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-09-27 | — | — | WO | disclosed |
| EP-1793667-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006034459-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2006-03-30 | — | — | WO | disclosed |
| US-4362552-A | OXALIC ACID, AMINES, PEROXIDATION | ETABLISSEMENTS HURET & FILS (BY CHANGE OF NAME NOW HURET & SES FILS) 60 AVENUE FELIX FAURE, NANTERRE (HAUTS DE SEINE), FRANCE, A FRENCH SOCIETY | 1982-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | ADRB2 39/4885ADRB1 21/4885ADRB3 48/4885 |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | ADRB2 39/4885ADRB1 21/4885ADRB3 48/4885 |
| US-20120053054-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALKBH3, ALKBH2, ALKBH1 | ADRB2 108/4885ADRB1 65/4885ADRB3 124/4885 |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | ALKBH3, ALKBH2, ALKBH1 | ADRB2 108/4885ADRB1 65/4885ADRB3 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.